About

With unwavering dedication, our team of scientists embarks on a mission to bring sight-restoring therapies to those in need, transforming lives and rekindling the light of vision.

---

Our Story

Limbustem, a research and development (R&D) company in the field of ophthalmology, produces and distributes advanced therapeutic products, specifically for ocular surface problems. The company is an academic spinoff focusing on life sciences & biotechnology and has its headquarters in Ege Technopark, Türkiye. Limbustem works in deep tech for the production of cellular/biological products, has also gained experience in completing the requirements of regulations based on European Medicines Agency (EMA).

Limbustem’s mission is to revolutionize eye care through the development and delivery of cutting-edge medical treatments for ocular surface diseases. The company is dedicated to advancing the field of ophthalmology by delivering innovative treatments that improve vision, enhance quality of life, and offer hope to patients worldwide. Its commitment to excellence pushes the boundaries of science and technology, ensuring that every treatment it develops meets the highest standards of safety, efficacy, and patient care. By collaborating with healthcare professionals, researchers, and the global community, it strives to make a lasting impact on eye health and contribute to a future where clear vision is a reality for everyone.

---

Meet the Team